The Effects of Progressive Muscle Relaxation Therapy in Patients With Schizophrenia: Randomized Controlled Trials
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Affective Disorders
- Sponsor
- Taipei Medical University
- Enrollment
- 75
- Primary Endpoint
- Quality of life simplified Chinese versions of the WHOQOL-BREF questionnaire were used
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
This study applied a randomized parallel case-controlled design. The study purpose was to evaluate the effects of progressive muscle relaxation on anxiety, psychiatric symptoms and quality of life among patients with chronic schizophrenia compared with an active control.
Detailed Description
Background: Anti-psychotic drugs are limited in their ability to improve psychiatric symptoms, quality of life, and anxiety status in patients with chronic schizophrenia. Progressive Muscle Relaxation (PMR) can potentially reduce anxiety status and improve subjective welling in acute patients. It is an ideal rehabilitation intervention for patients with chronic schizophrenia. However, no study has investigated the effects of PMR on outcomes among patients with chronic schizophrenia. Design: This study applied a randomized parallel case-controlled design. Methods: Hospital-based randomized control trial in Taiwan. Eighty subjects with chronic schizophrenia were recruited from a psychotic ward and randomized into PMR, or control groups. Patients in the intervention group participated in progressive muscle relaxation for 12 weeks; while patients in the control group members received supportive treatment-as-usual (TAU). All participants completed anxiety, psychotic syndromes and quality of life measures at baseline, 3-month, and 3-month follow-up.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinical diagnosis of Schizophrenia
- •Without the risk of self-injury and violence
- •Patients aged from 20-65 years old
- •Had no alcohol and drug abuse
- •Can use Mandarin or Taiwanese to communicate
Exclusion Criteria
- •Patients with another psychiatric comorbidity
- •Patients with musculoskeletal problems
- •patients who cannot sit last for 50 minutes
- •Had received progressive muscle relaxation training within the last year
- •Diagnosis of confirmed cardiovascular disease
Outcomes
Primary Outcomes
Quality of life simplified Chinese versions of the WHOQOL-BREF questionnaire were used
Time Frame: Measuring changes in quality of life from baseline to 6 months.
a 28-item questionnaire rated on a five-point Likert scale with four domains measuring: psychological health, physical health, social relationships and environment.so that higher scores refer to high QOL.
Secondary Outcomes
- Positive and Negative Syndrome Scale (PANSS)(measured at baseline, 3-month, and 3-month follow-up)
- Anxiety Scale(measured at baseline, 3-month, and 3-month follow-up)